Nakatani-Enomoto Setsu, Hanajima Ritstuko, Hamada Masashi, Matsumoto Hideyuki, Terao Yasuo, Jun Groiss Stefan, Murakami Takenobu, Abe Mitsunari, Enomoto Hiroyuki, Kawai Kensuke, Kan Rumiko, Niwa Shin-Ichi, Yabe Hirooki, Ugawa Yoshikazu
Department of Neurology, School of Medicine, Fukushima Medical University, Fukushima, Japan.
Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Clin Neurophysiol Pract. 2023 Jul 7;8:137-142. doi: 10.1016/j.cnp.2023.07.001. eCollection 2023.
This study aimed to assess the efficacy and safety of quadripulse transcranial magnetic stimulation-50 (QPS-50) in patients with intractable epilepsy.
Four patients were included in the study. QPS-50, which induces long-term depression in healthy subjects, was administered for 30 min on a weekly basis for 12 weeks. Patients' clinical symptoms and physiological parameters were evaluated before, during, and after the repeated QPS-50 period. We performed two control experiments: the effect in MEP (Motor evoked potential) size after a single QPS-50 session with a round coil in nine healthy volunteers, and a follow-up study of physiological parameters by repeated QPS-50 sessions in four other healthy participants.
Motor threshold (MT) decreased during the repeated QPS-50 sessions in all patients. Epileptic symptoms worsened in two patients, whereas no clinical worsening was observed in the other two patients. In contrast, MT remained unaffected for 12 weeks in all healthy volunteers.
QPS-50 may not be effective as a treatment for intractable epilepsy.
In intractable epilepsy patients, administering repeated QPS-50 may paradoxically render the motor cortex more excitable, probably because of abnormal inhibitory control within the epileptic cortex. The possibility of clinical aggravation should be seriously considered when treating intractable epilepsy patients with non-invasive stimulation methods.
本研究旨在评估四脉冲经颅磁刺激-50(QPS-50)治疗难治性癫痫患者的疗效和安全性。
本研究纳入4例患者。QPS-50可在健康受试者中诱导长时程抑制,每周给药1次,每次30分钟,共给药12周。在重复进行QPS-50治疗前、治疗期间和治疗后,对患者的临床症状和生理参数进行评估。我们进行了两项对照实验:在9名健康志愿者中使用圆形线圈单次进行QPS-50治疗后对运动诱发电位(MEP)大小的影响,以及在另外4名健康参与者中通过重复进行QPS-50治疗对生理参数的随访研究。
在所有患者重复进行QPS-50治疗期间,运动阈值(MT)均下降。2例患者癫痫症状加重,而另外2例患者未观察到临床症状恶化。相比之下,所有健康志愿者的MT在12周内均未受影响。
QPS-50可能不是治疗难治性癫痫的有效方法。
在难治性癫痫患者中,重复进行QPS-50治疗可能反常地使运动皮层更易兴奋,这可能是由于癫痫皮层内异常的抑制控制所致。在用非侵入性刺激方法治疗难治性癫痫患者时,应认真考虑临床症状加重的可能性。